← Back to Analyst Consensus 
CVS Buy
CVS HEALTH Corp
Current Price —
Implied Upside —
Analysts 32
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Sep 3, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 19, 2026 | Argus Research | maintain | Buy → Buy | — | 54% |
| Aug 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 6, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 24, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 14, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 13, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 9, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 7, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Jun 23, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Jun 8, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jun 4, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jun 1, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 26, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 20, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 14, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 13, 2026 | Bernstein | maintain | Outperform → Outperform | — | 52% |
| May 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 11, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 7, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Apr 15, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 31, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Mar 12, 2026 | Bernstein | upgrade | Market Perform → Outperform | — | 52% |
| Jan 28, 2026 | Argus Research | maintain | Buy → Buy | $90 | 54% |
| Jan 27, 2026 | B of A Securities | maintain | Buy → Buy | $95 | 53% |
| Jan 6, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| Dec 17, 2025 | JP Morgan | maintain | Overweight → Overweight | $101 | 55% |
| Dec 12, 2025 | Bernstein | maintain | Market Perform → Market Perform | $87 | 52% |
| Dec 10, 2025 | Truist Securities | maintain | Buy → Buy | $98 | 54% |
| Dec 10, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $101 | 54% |
| Dec 10, 2025 | UBS | maintain | Buy → Buy | $97 | 54% |
| Dec 10, 2025 | Barclays | maintain | Overweight → Overweight | $93 | 53% |
| Dec 10, 2025 | Mizuho | maintain | Outperform → Outperform | $95 | 52% |
| Dec 10, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $93 | 54% |
| Dec 10, 2025 | Baird | maintain | Outperform → Outperform | $92 | 55% |
| Dec 5, 2025 | Bernstein | maintain | Market Perform → Market Perform | $86 | 52% |
| Nov 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $102 | 54% |
| Nov 3, 2025 | TD Cowen | maintain | Buy → Buy | $100 | 54% |
| Oct 30, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $95 | 58% |
| Oct 30, 2025 | RBC Capital | maintain | Outperform → Outperform | $93 | 55% |
| Oct 30, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $95 | 50% |
| Oct 30, 2025 | Truist Securities | reiterate | Buy → Buy | $95 | 54% |
Price Target Trend
Jul 14, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days